Prot #AR-301-002: A Randomized Double-blind Placebo-controlled Multicenter Phase 3 Study of Efficacy and Safety of AR-301 as Adjunct Therapy to Antibiotics in the Treatment of Ventilator-Associated Pneumonia (VAP) Caused by S. aureus

Project: Research project

Project Details

StatusFinished
Effective start/end date3/9/20 → 3/9/23

Funding

  • Pharm-Olam International Ltd. ((OE) Prot #AR-301-002 // (OE) Prot #AR-301-002)
  • Aridis Pharmaceuticals, Inc. ((OE) Prot #AR-301-002 // (OE) Prot #AR-301-002)